(Nasdaq: EXEL) today announced results from a subgroup analysis of the CABINET phase 3 pivotal trial evaluating CABOMETYX ® (cabozantinib) versus placebo in patients with previously treated advanced ...

Phase II trial shows belzutifan effectively shrinks rare neuroendocrine tumors and improves symptoms, offering hope for ...

Everyone gets headaches. Everyone misplaces their phone or forgets a name now and then. Most of the time, these moments are ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Improvements in survival were seen for those residing in rural and high-poverty communities in Medicaid expansion states.

While in the fourth year of pursuing her doctorate in immunology at the University of Minnesota, Anderson was diagnosed with ...

For Stephen Greene, an attorney and father of two, the first symptoms of a brain tumor were subtle — and not obviously linked ...

Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s ...

Cancer rates in young people are growing, and those in the GI tract are rising fastest of all. Here are five things to know about colorectal cancer from an expert.

A dentist lists down probable causes why teeth colour changes to yellow. She also advises against whitening treatments.